These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
336 related articles for article (PubMed ID: 10453029)
1. Regulation of IL-15-stimulated TNF-alpha production by rolipram. Kasyapa CS; Stentz CL; Davey MP; Carr DW J Immunol; 1999 Sep; 163(5):2836-43. PubMed ID: 10453029 [TBL] [Abstract][Full Text] [Related]
2. Impact of VIP and cAMP on the regulation of TNF-alpha and IL-10 production: implications for rheumatoid arthritis. Foey AD; Field S; Ahmed S; Jain A; Feldmann M; Brennan FM; Williams R Arthritis Res Ther; 2003; 5(6):R317-28. PubMed ID: 14680506 [TBL] [Abstract][Full Text] [Related]
3. Interleukin-10 does not mediate the inhibitory effect of PDE-4 inhibitors and other cAMP-elevating drugs on lipopolysaccharide-induced tumors necrosis factor-alpha generation from human peripheral blood monocytes. Seldon PM; Barnes PJ; Giembycz MA Cell Biochem Biophys; 1998; 29(1-2):179-201. PubMed ID: 9631245 [TBL] [Abstract][Full Text] [Related]
4. IL-17 stimulates the production and expression of proinflammatory cytokines, IL-beta and TNF-alpha, by human macrophages. Jovanovic DV; Di Battista JA; Martel-Pelletier J; Jolicoeur FC; He Y; Zhang M; Mineau F; Pelletier JP J Immunol; 1998 Apr; 160(7):3513-21. PubMed ID: 9531313 [TBL] [Abstract][Full Text] [Related]
5. Cytokine stimulation of T lymphocytes regulates their capacity to induce monocyte production of tumor necrosis factor-alpha, but not interleukin-10: possible relevance to pathophysiology of rheumatoid arthritis. Sebbag M; Parry SL; Brennan FM; Feldmann M Eur J Immunol; 1997 Mar; 27(3):624-32. PubMed ID: 9079801 [TBL] [Abstract][Full Text] [Related]
6. Suppression of TNF-alpha expression, inhibition of Th1 activity, and amelioration of collagen-induced arthritis by rolipram. Ross SE; Williams RO; Mason LJ; Mauri C; Marinova-Mutafchieva L; Malfait AM; Maini RN; Feldmann M J Immunol; 1997 Dec; 159(12):6253-9. PubMed ID: 9550429 [TBL] [Abstract][Full Text] [Related]
7. Interleukin-18 enhances monocyte tumor necrosis factor alpha and interleukin-1beta production induced by direct contact with T lymphocytes: implications in rheumatoid arthritis. Dai SM; Matsuno H; Nakamura H; Nishioka K; Yudoh K Arthritis Rheum; 2004 Feb; 50(2):432-43. PubMed ID: 14872485 [TBL] [Abstract][Full Text] [Related]
8. Phosphodiesterase 4 inhibitors prevent cytokine secretion by T lymphocytes by inhibiting nuclear factor-kappaB and nuclear factor of activated T cells activation. Jimenez JL; Punzón C; Navarro J; Muñoz-Fernández MA; Fresno M J Pharmacol Exp Ther; 2001 Nov; 299(2):753-9. PubMed ID: 11602691 [TBL] [Abstract][Full Text] [Related]
9. Differential cytokine modulation and T cell activation by two distinct classes of thalidomide analogues that are potent inhibitors of TNF-alpha. Corral LG; Haslett PA; Muller GW; Chen R; Wong LM; Ocampo CJ; Patterson RT; Stirling DI; Kaplan G J Immunol; 1999 Jul; 163(1):380-6. PubMed ID: 10384139 [TBL] [Abstract][Full Text] [Related]
10. In vitro anti-inflammatory activity of Phlebodium decumanum. Modulation of tumor necrosis factor and soluble TNF receptors. Punzón C; Alcaide A; Fresno M Int Immunopharmacol; 2003 Sep; 3(9):1293-9. PubMed ID: 12890427 [TBL] [Abstract][Full Text] [Related]
11. Increased activation of protein kinase A type I contributes to the T cell deficiency in common variable immunodeficiency. Aukrust P; Aandahl EM; Skålhegg BS; Nordøy I; Hansson V; Taskén K; Frøland SS; Müller F J Immunol; 1999 Jan; 162(2):1178-85. PubMed ID: 9916750 [TBL] [Abstract][Full Text] [Related]
12. Suppression of TNF-alpha production in human mononuclear cells by an adenosine kinase inhibitor. Eigler A; Matschke V; Hartmann G; Erhardt S; Boyle D; Firestein GS; Endres S J Leukoc Biol; 2000 Jul; 68(1):97-103. PubMed ID: 10914495 [TBL] [Abstract][Full Text] [Related]
13. IL-18-induced expression of intercellular adhesion molecule-1 in human monocytes: involvement in IL-12 and IFN-gamma production in PBMC. Yoshida A; Takahashi HK; Nishibori M; Iwagaki H; Yoshino T; Morichika T; Yokoyama M; Kondo E; Akagi T; Tanaka N Cell Immunol; 2001 Jun; 210(2):106-15. PubMed ID: 11520077 [TBL] [Abstract][Full Text] [Related]
14. Induction of various immune modulatory molecules in CD34(+) hematopoietic cells. Umland O; Heine H; Miehe M; Marienfeld K; Staubach KH; Ulmer AJ J Leukoc Biol; 2004 Apr; 75(4):671-9. PubMed ID: 14742640 [TBL] [Abstract][Full Text] [Related]
15. Differential regulation of human monocyte-derived TNF alpha and IL-1 beta by type IV cAMP-phosphodiesterase (cAMP-PDE) inhibitors. Verghese MW; McConnell RT; Strickland AB; Gooding RC; Stimpson SA; Yarnall DP; Taylor JD; Furdon PJ J Pharmacol Exp Ther; 1995 Mar; 272(3):1313-20. PubMed ID: 7891349 [TBL] [Abstract][Full Text] [Related]
16. Stimulation of IL-2-activated natural killer cells through the Kp43 surface antigen up-regulates TNF-alpha production involving the LFA-1 integrin. Aramburu J; Balboa MA; Rodríguez A; Melero I; Alonso M; Alonso JL; López-Botet M J Immunol; 1993 Oct; 151(7):3420-9. PubMed ID: 8104219 [TBL] [Abstract][Full Text] [Related]
17. The phosphodiesterase i.v. inhibitor rolipram in vitro reduces the numbers of MBP-reactive IFN-gamma and TNF-alpha mRNA expressing blood mononuclear cells in patients with multiple sclerosis. Navikas V; Matusevicius D; Söderström M; Pirskanen R; Fredrikson S; Link H Clin Neuropharmacol; 1998; 21(4):236-44. PubMed ID: 9704165 [TBL] [Abstract][Full Text] [Related]
18. IL-4 expression in human T cells is selectively inhibited by IL-1 alpha and IL-1 beta. Sandborg CI; Imfeld KL; Zaldivar F; Wang Z; Buckingham BA; Berman MA J Immunol; 1995 Dec; 155(11):5206-12. PubMed ID: 7594531 [TBL] [Abstract][Full Text] [Related]
19. Activation of the cAMP-dependent signaling pathway downregulates the expression of interleukin-3 and granulocyte-macrophage colony-stimulating factor in activated human T lymphocytes. Borger P; Kauffman HF; Vijgen JL; Postma DS; Vellenga E Exp Hematol; 1996 Feb; 24(2):108-15. PubMed ID: 8641331 [TBL] [Abstract][Full Text] [Related]
20. Cyclic nucleotide phosphodiesterase type IV participates in the regulation of IL-10 and in the subsequent inhibition of TNF-alpha and IL-6 release by endotoxin-stimulated macrophages. Kambayashi T; Jacob CO; Zhou D; Mazurek N; Fong M; Strassmann G J Immunol; 1995 Nov; 155(10):4909-16. PubMed ID: 7594495 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]